Clinical Trial Update: The ORIGIN-FH Study [NA]

View source ↗

Summary

The ORIGIN-FH clinical trial is currently recruiting to study familial hypercholesterolemia, including heterozygous and homozygous forms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Heterozygous Familial Hypercholesterolemia
• Homozygous Familial Hypercholesterolemia

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH) | NA | Status: RECRUITING